Transmyocardial laser revascularization: Operative techniques and clinical results at two years

被引:172
作者
Horvath, KA
Mannting, F
Cummings, N
Shernan, SK
Cohn, LH
机构
[1] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT CARDIAC SURG,BOSTON,MA 02115
[2] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT NUCL MED,BOSTON,MA 02115
[3] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT ANESTHESIOL,BOSTON,MA 02115
关键词
D O I
10.1016/S0022-5223(96)70381-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: A new technique, transmyocardial laser revascularization, provides direct perfusion of ischemic myocardium via laser-created transmural channels. From 1993 to 1995, we have treated 20 patients (mean age 61 years, four women and 16 men) with transmyocardial laser revascularization. Preoperatively, the average angina class was 3.7. The patients were screened before the operation by a technetium sestamibi perfusion scan to identify the location and extent of their reversible ischemia. Methods: Operative exposure is gained via a left anterior thoracotomy. With the use of a 850-watt carbon dioxide laser, an average of 21 +/- 4 channels were created in 22 minutes with a total operative time of less than 2 hours. Results: The in-hospital mortality was two of 20 patients. Three additional patients died after discharge. After an accumulated 172 patient-months (mean follow-up 11 +/- 8 months, range 1 to 26 months), the mean angina class is I (p = 0.01). Postoperative sestamibi scans were obtained at 3, 6, and 12 months. Using the septum as a control and comparing the postoperative results with the preoperative baseline, we noted a significant improvement in perfusion particularly in the areas of reversible ischemia. Conclusion: These early results indicate that transmyocardial laser revascularization is a simple operative technique that may improve myocardial perfusion and provide angina relief for patients in whom standard methods of revascularization is contraindicated.
引用
收藏
页码:1047 / 1052
页数:6
相关论文
共 28 条
[1]   EXPERIMENTAL GRAFT ARTERIOSCLEROSIS .2. IMMUNOCYTOCHEMICAL ANALYSIS OF LESION DEVELOPMENT [J].
ADAMS, DH ;
WYNER, LR ;
KARNOVSKY, MJ .
TRANSPLANTATION, 1993, 56 (04) :794-799
[2]   EXPERIMENTAL EVALUATION OF MYOCARDIAL TUNNELIZATION AS A METHOD OF MYOCARDIAL REVASCULARIZATION [J].
ANABTAWI, IN ;
REIGLER, HF ;
ELLISON, RG .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1969, 58 (05) :638-&
[3]   The development of a new blood supply to the heart by operation [J].
Beck, CS .
ANNALS OF SURGERY, 1935, 102 :801-813
[4]  
BERMAN DS, 1991, CIRCULATION S, V84, P17
[5]   DISTRIBUTION OF CORONARY BLOOD-FLOW ACROSS CANINE HEART WALL DURING SYSTOLE [J].
DOWNEY, JM ;
KIRK, ES .
CIRCULATION RESEARCH, 1974, 34 (02) :251-257
[6]  
Eich D M, 1990, Cardiovasc Clin, V20, P199
[7]   ANGIOGENIC FACTORS [J].
FOLKMAN, J ;
KLAGSBRUN, M .
SCIENCE, 1987, 235 (4787) :442-447
[8]  
FRAZIER OH, 1995, CIRCULATION S, V90, P640
[9]  
FYFE AI, 1992, CAN J CARDIOL, V8, P509
[10]  
HOCKEL M, 1993, ARCH SURG-CHICAGO, V128, P423